Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis
Authors:
- 19 June 2012
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 39 (8) , 8431-8437
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Adenylate Kinase 3 Sensitizes Cells to Cigarette Smoke Condensate Vapor Induced Cisplatin ResistancePLOS ONE, 2011
- RASSF1ASmall GTPases, 2011
- Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samplesGenome Research, 2010
- Genetic and Epigenetic Alterations of Familial Pancreatic CancersCancer Epidemiology, Biomarkers & Prevention, 2008
- Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor PrognosisPLOS Medicine, 2008
- Frequent epigenetic inactivation of Wnt antagonist genes in breast cancerBritish Journal of Cancer, 2008
- The Epigenomics of CancerCell, 2007
- SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactionsOncogene, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Bisulfite-catalyzed transamination of cytosine and cytidineBiochemical and Biophysical Research Communications, 1970